Table 1.
Baseline characteristics across LOC.
Level 1 (n = 2,830) | Level 1A (n = 3,452) | Level 2 (n = 340) | Level 3 (n = 780) | p-value | |
---|---|---|---|---|---|
Age (median, IQR) | 69 (60–78) | 71 (61–80) | 77 (67–85) | 77 (67–85) | <0.0001 |
Length of stay, days (median, IQR) | 13 (7–24) | 9 (4–16) | 4 (1–10) | 6 (2–13.7) | <0.0001 |
Sex, male, n (%) | 1,796 (63.4%) | 2,149 (62.3%) | 209 (61.5%) | 416 (53.3%) | <0.0001 |
Insurance | <0.0001 | ||||
Medicare/Medicaid (%) | 86.4% | 89.1% | 92.1% | 92.6% | |
Private (%) | 11.8% | 9.8% | 6.2% | 6.2% | |
Other (%) | 1.8% | 1.2% | 1.5% | 1.3% | |
HTN, n (%) | 1,967 (69.5%) | 2,143 (62.1%) | 175 (51.5%) | 578 (74.1%) | <0.0001 |
CKD, n (%) | 938 (33.1%) | 959 (27.8%) | 87 (25.6%) | 237 (30.4%) | <0.0001 |
HF, n (%) | 1,623 (57.3%) | 1,801 (52.2%) | 134 (39.4%) | 438 (56.2%) | <0.0001 |
CAD, n (%) | 1,339 (47.3%) | 1,254 (36.3%) | 115 (33.8%) | 220 (28.2%) | <0.0001 |
DM2, n (%) | 1,218 (43.0%) | 1,305 (37.8%) | 85 (25.0%) | 323 (41.4%) | <0.0001 |
Atrial fibrillation, n (%) | 1,177 (41.6%) | 1,189 (34.4%) | 106 (31.2%) | 310 (39.7%) | <0.0001 |
VTE, n (%) | 64 (2.3%) | 39 (1.1%) | 2 (0.6%) | 6 (0.8%) | 0.0003 |
Anemia, n (%) | 1,018 (36.0%) | 1,089 (31.5%) | 76 (22.4%) | 295 (37.8%) | <0.0001 |
Cardiac arrest at admission, n (%) | 78 (2.8%) | 165 (4.8%) | 45 (13.2%) | 94 (12.1%) | <0.0001 |
Admission type | |||||
Emergency room, n (%) | 1,304 (46.1%) | 2,547 (73.8%) | 331 (97.4%) | 748 (95.9%) | <.0.0001 |
Transfer in | 1,129 (40%) | 583 (17%) | 3 (0.9%) | 21 (2.7%) | <.0.0001 |
Other | 396 (14.0%) | 322 (9.3%) | 6 (1.7%) | 11 (1.4%) | <0.0001 |
Shock etiologies | |||||
AMI | 887 (31.3%) | 961 (27.8%) | 108 (31.8%) | 66 (8.5%) | <0.0001 |
AHF | 971 (34.3%) | 1,089 (31.5%) | 59 (17.4%) | 137 (17.6%) | <0.0001 |
Other (%) | 972 (34.3%) | 1,402 (40.6%) | 173 (50.9%) | 577 (74.0%) | <0.0001 |
Sepsis (% of “other”) | 417 (42.9%) | 628 (44.8%) | 81 (46.8%) | 320 (55.5%) | <0.0001 |
Pulmonary embolism (% of “other”) | 45 (4.6%) | 37 (2.6%) | 4 (2.3%) | 14 (2.4%) | 0.0245 |
Other non-cardiac (% of “other”) | 300 (30.9%) | 367 (26.2%) | 55 (31.8%) | 128 (22.2%) | <0.0009 |
CAD, coronary artery disease; CKD, chronic kidney disease; DM2, diabetes mellitus type 2; HTN, hypertension; VTE, venous thromboembolism.